A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
Status:
Completed
Trial end date:
2020-12-17
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in
healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic
efficacy of AG-920 Sterile Topical Ophthalmic Solution.